Yaqin Liu

State Key Laboratory Of Natural Medicines
Nanjing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Conformation-Guided Disulfide Pairing Enables Efficient Folding of Disulfide-Rich Peptides.

Conformation-Guided Disulfide Pairing Enables Efficient Folding of Disulfide-Rich Peptides.

Journal: Angewandte Chemie (International ed. in English)

Published: February 07, 2026

Intrathecal pemetrexed for leptomeningeal metastasis from lung adenocarcinoma: a clinical efficacy and multiplex liquid proteomics exploration study.

Intrathecal pemetrexed for leptomeningeal metastasis from lung adenocarcinoma: a clinical efficacy and multiplex liquid proteomics exploration study.

Journal: The oncologist

Published: March 30, 2025

Mutation patterns and prognostic potentiality of homologous recombination repair genes in gliomas.

Mutation patterns and prognostic potentiality of homologous recombination repair genes in gliomas.

Journal: BMC cancer

Published: February 22, 2025

Stereotactic body radiotherapy with sintilimab and bevacizumab biosimilar in anti-PD-1 refractory hepatocellular carcinoma: the ReUNION-1 phase 2 trial.

Stereotactic body radiotherapy with sintilimab and bevacizumab biosimilar in anti-PD-1 refractory hepatocellular carcinoma: the ReUNION-1 phase 2 trial.

Journal: Nature communications

Published: February 09, 2025

DYNC2H1 mutation as a potential predictive biomarker for immune checkpoint inhibitor efficacy in NSCLC and melanoma.

DYNC2H1 mutation as a potential predictive biomarker for immune checkpoint inhibitor efficacy in NSCLC and melanoma.

Journal: Investigational new drugs

Published: November 26, 2024

Unraveling the potential biomarkers of immune checkpoint inhibitors in advanced ovarian cancer: a comprehensive review.

Unraveling the potential biomarkers of immune checkpoint inhibitors in advanced ovarian cancer: a comprehensive review.

Journal: Investigational new drugs

Published: September 06, 2024

Development and validation of a prognostic and drug sensitivity model for gastric cancer utilizing telomere-related genes.

Development and validation of a prognostic and drug sensitivity model for gastric cancer utilizing telomere-related genes.

Journal: Translational oncology

Published: July 29, 2024

PTCH1 mutation as a potential predictive biomarker for immune checkpoint inhibitors in gastrointestinal cancer.

PTCH1 mutation as a potential predictive biomarker for immune checkpoint inhibitors in gastrointestinal cancer.

Journal: Carcinogenesis

Published: August 30, 2023

POTEE mutation as a potential predictive biomarker for immune checkpoint inhibitors in lung adenocarcinoma.

POTEE mutation as a potential predictive biomarker for immune checkpoint inhibitors in lung adenocarcinoma.

Journal: Investigational new drugs

Published: May 04, 2023

Liquid biopsy using cell-free DNA in the early diagnosis of hepatocellular carcinoma.

Liquid biopsy using cell-free DNA in the early diagnosis of hepatocellular carcinoma.

Journal: Investigational new drugs

Published: March 24, 2023

Phosphorylation of bip130 by OsMPK1 regulates abscisic acid-induced antioxidant defense in rice.

Phosphorylation of bip130 by OsMPK1 regulates abscisic acid-induced antioxidant defense in rice.

Journal: Biochemical and biophysical research communications

Published: April 25, 2019

Showing 1-11 of 11

Last Updated: 09/26/2026